179 related articles for article (PubMed ID: 26752214)
21. Enhanced intracellular peptide delivery by multivalent cell-penetrating peptide with bioreducible linkage.
Kim H; Kitamatsu M; Ohtsuki T
Bioorg Med Chem Lett; 2018 Feb; 28(3):378-381. PubMed ID: 29275934
[TBL] [Abstract][Full Text] [Related]
22. A biophysical elucidation for less toxicity of agglutinin than abrin-a from the seeds of Abrus precatorius in consequence of crystal structure.
Cheng J; Lu TH; Liu CL; Lin JY
J Biomed Sci; 2010 Apr; 17(1):34. PubMed ID: 20433687
[TBL] [Abstract][Full Text] [Related]
23. Novel cell-penetrating peptides based on α-aminoxy acids.
Ma Y; Yang D; Ma Y; Zhang YH
Chembiochem; 2012 Jan; 13(1):73-9. PubMed ID: 22162305
[TBL] [Abstract][Full Text] [Related]
24. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
25. Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation.
Saka R; Chella N; Khan W
AAPS PharmSciTech; 2021 Jun; 22(5):192. PubMed ID: 34184160
[TBL] [Abstract][Full Text] [Related]
26. Structure-function analysis and insights into the reduced toxicity of Abrus precatorius agglutinin I in relation to abrin.
Bagaria A; Surendranath K; Ramagopal UA; Ramakumar S; Karande AA
J Biol Chem; 2006 Nov; 281(45):34465-74. PubMed ID: 16772301
[TBL] [Abstract][Full Text] [Related]
27. Cell-penetrating peptide exploited syndecans.
Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
[TBL] [Abstract][Full Text] [Related]
28. Peptide-mediated protein delivery-which pathways are penetrable?
Räägel H; Säälik P; Pooga M
Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
[TBL] [Abstract][Full Text] [Related]
29. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
[TBL] [Abstract][Full Text] [Related]
30. Peptide internalization enabled by folding: triple helical cell-penetrating peptides.
Shinde A; Feher KM; Hu C; Slowinska K
J Pept Sci; 2015 Feb; 21(2):77-84. PubMed ID: 25524829
[TBL] [Abstract][Full Text] [Related]
31. Cellular Uptake of IgG Using Collagen-Like Cell-Penetrating Peptides.
Masuda R; Yamamoto K; Koide T
Biol Pharm Bull; 2016; 39(1):130-4. PubMed ID: 26725435
[TBL] [Abstract][Full Text] [Related]
32. Human-protein-derived peptides for intracellular delivery of biomolecules.
Haas AK; Maisel D; Adelmann J; von Schwerin C; Kahnt I; Brinkmann U
Biochem J; 2012 Mar; 442(3):583-93. PubMed ID: 22150630
[TBL] [Abstract][Full Text] [Related]
33. Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery.
Hörner S; Knauer S; Uth C; Jöst M; Schmidts V; Frauendorf H; Thiele CM; Avrutina O; Kolmar H
Angew Chem Int Ed Engl; 2016 Nov; 55(47):14842-14846. PubMed ID: 27774725
[TBL] [Abstract][Full Text] [Related]
34. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
[TBL] [Abstract][Full Text] [Related]
35. A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.
Lim KJ; Sung BH; Shin JR; Lee YW; Kim DJ; Yang KS; Kim SC
PLoS One; 2013; 8(6):e66084. PubMed ID: 23776609
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes.
Kadivar A; Kamalidehghan B; Akbari Javar H; Karimi B; Sedghi R; Noordin MI
Drug Des Devel Ther; 2017; 11():469-481. PubMed ID: 28260860
[TBL] [Abstract][Full Text] [Related]
37. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
[TBL] [Abstract][Full Text] [Related]
38. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
39. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
40. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
